I. Medizinische Klinik und Poliklinik, Schwerpunkt Endokrinologie und Stoffwechselkrankheiten
Klinikum / Johannes Gutenberg-Universität Mainz
Dultz, G; Matheis, N; Dittmar, M et al.
The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetesThyroid. Bd. 19. H. 2. 2009 S. 143-8
Wiedemeir, S; Grodrian, A; Zimmermann, H et al.
Therapie des Diabetes mellitus mittels Immunisolierter-InselzellenBIOforum. Bd. 01. 2009 S. 14-16
Ponto, KA; Kahaly, GJ; Pitz, S
Update endokrine OrbitopathieKlin Monatsbl Augenheilkd. Bd. 226. H. 2. 2009 S. R13-28; quiz R29-31
Pfutzner, A; Weber, MM; Forst, T
A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus.Clin Lab. Bd. 54. H. 11-12. 2008 S. 485-90
Dietlein, M; Kahaly, G; Kobe, C et al.
Adipositas, Stoffwechsel und Schilddruse. Ist der grenzwertig hohe TSH-Spiegel Ursache oder Sekundarphanomen der Adipositas?Nuklearmedizin. Bd. 47. H. 5. 2008 S. 181-7
Jensterle, M; Weber, MM; Pfeifer, M et al.
Assessment of insulin resistance in young women with polycystic ovary syndrome.Int J Gynecol Obstet. Bd. 102. 2008 S. 137-140
Meyer, S; Haist, M; Schaefer, S et al.
Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults.Pharmacogenomics. Bd. 9. H. 8. 2008 S. 1017-26
Pfutzner, A; Weber, MM; Forst, T
Biomarkers for Assessing Beta-Cell Function and Insulin Resistance in Type 2 DiabetesDiabetes Stoffwechsel und Herz. Bd. 17. H. Supp. 2008 S. 37-41
Bartalena, L; Baldeschi, L; Dickinson, A et al.
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.Eur J Endocrinol. Bd. 158. H. 3. 2008 S. 273-85
Dittmar, M; Ide, M; Wurm, M et al.
Early onset of polyglandular failure is associated with HLA-DRB1*03.Eur J Endocrinol. Bd. 159. H. 1. 2008 S. 55-60